SEC

New York, NY (November 27, 2024) – Fr. Emmanuel Lemelson today filed an opening brief with the U.S. Court of Appeals for the First Circuit seeking to reverse a...

“Not only was the jury unconvinced by the SEC's showing with regard to misstatements, the jury outright rejected the SEC's fraudulent scheme charge; the jury al...

Lemelson Capital Chief Comments on Unprecedented 9-year SEC Fight over Ligand Pharmaceuticals (NASDAQ: LGND) Jerricho, New York, December 12, 2023 — Rev. Emmanu...

Rev. Father Emmanuel Lemelson and Lemelson Capital Mgmt., LLC v. Securities and Exchange Commission Shelburn, VT (August 1, 2023) – Whistleblower and activist i...

Fr. Emmanuel Lemelson Comments on Jury Verdict Jury Verdict Finds Fr. Emmanuel "Not Liable" For Key Allegations Shelburne, Vermont, November 5, 2021 —The Rev. E...

To read the full Opposition click here or view on Scribd below. "That is, the Commission promoted Ligand’s stock price in its Complaint, which was riddled with...

To read the full Motion For Summary Judgment click here or view on Scribd below with the statement of facts and exhibits. To say this enforcement action is unpr...

To read the full affidavit click here or view below on Scribd with the complete list of exhibits attached. In March 2020 Fr. Emmanuel Lemelson was held in conte...

On January 28, 2020, U.S. magistrate judge Donald L. Cabell, ruled in favor of Rev. Fr. Emmanuel Lemelson, denying the SEC request for a protective order and gr...

Lemelson Capital Management To Announce Fiscal 2019 Results For The Amvona Fund, LP On January 21, 2020 Watch! "This Is A Rigged Game" As Ligand Pharmaceuticals...

To read the full Opposition to The Securities and Exchange Commission's motion for protective order click here or view on Scribd below. For more background see...

Fr. Emmanuel Lemelson speaks out against alleged fraud and complicit regulators as Ligand shares continue to implode, heading towards new multi-year lows Shelbu...